Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder

Journal of Psychiatric Research

Volumn 46, Issue 8, 2012, Pages 1024-1028

  Hamazaki, Kei ^a   Hamazaki, Tomohito ^a,b   Inadera, Hidekuni ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Toyama Jonan Onsen Daini Hospital   (Japan)

Author keywords

AA; Bipolar disorder; Case control study; DHA; DPA; Major depressive disorder; MDD; Polyunsaturated fatty acids; Postmortem brain; PUFAs; Schizophrenia; SMRI

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BIPOLAR DISORDER; BRAIN; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MAJOR DEPRESSION; MALE; ORBITAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 84863483992     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.04.012     Document Type: Article

References (41)

1. Altshuler L.L., Abulseoud O.A., Foland-Ross L., Bartzokis G., Chang S., Mintz J., et al. Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disorders 2010, 12:541-549.
2. Autry A.E., Monteggia L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacological Reviews 2012, 64:238-258.
3. Berretta S., Pantazopoulos H., Lange N. Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia. Biological Psychiatry 2007, 62:884-893.
4. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959, 37:911-917.
5. Bloch M.H., Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Molecular Psychiatry 2011.
6. Bora E., Fornito A., Pantelis C., Yucel M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. Journal of Affective Disorders 2011.
7. Bowley M.P., Drevets W.C., Ongur D., Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 2002, 52:404-412.
8. Bugajski J. Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neurohormone systems. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 1996, 47:559-575.
9. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. Journal of Neurochemistry 1996, 66:1582-1591.
10. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. The Journal of Clinical Psychiatry 2006, 67:1954-1967.
11. Hamazaki K., Choi K.H., Kim H.Y. Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species. Journal of Psychiatric Research 2010, 44:688-693.
12. Hamidi M., Drevets W.C., Price J.L. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biological Psychiatry 2004, 55:563-569.
13. Hibbeln J.R., Bissette G., Umhau J.C., George D.T. Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence. Biological Psychiatry 2004, 56:895-897.
14. Hibbeln J.R., Linnoila M., Umhau J.C., Rawlings R., George D.T., Salem N. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biological Psychiatry 1998, 44:235-242.
15. Huan M., Hamazaki K., Sun Y., Itomura M., Liu H., Kang W., et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biological Psychiatry 2004, 56:490-496.
16. Kodas E., Galineau L., Bodard S., Vancassel S., Guilloteau D., Besnard J.C., et al. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. Journal of Neurochemistry 2004, 89:695-702.
17. Kreczmanski P., Heinsen H., Mantua V., Woltersdorf F., Masson T., Ulfig N., et al. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain: A Journal of Neurology 2007, 130:678-692.
18. Lalovic A., Levy E., Canetti L., Sequeira A., Montoudis A., Turecki G. Fatty acid composition in postmortem brains of people who completed suicide. Journal of Psychiatry & Neuroscience 2007, 32:363-370.
19. Lewis M.D., Hibbeln J.R., Johnson J.E., Lin Y.H., Hyun D.Y., Loewke J.D. Suicide deaths of active-duty US military and omega-3 fatty-acid status: a case-control comparison. The Journal of Clinical Psychiatry 2011.
20. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 2010, 68:140-147.
21. Liu Y., Jandacek R., Rider T., Tso P., McNamara R.K. Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: relationship with fatty acid composition. Schizophrenia Research 2009, 109:113-120.
22. Matsuoka Y., Nishi D., Yonemoto N., Hamazaki K., Hamazaki T., Hashimoto K. Potential role of brain-derived neurotrophic factor in omega-3 Fatty Acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study. Psychotherapy and Psychosomatics 2011, 80:310-312.
23. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biological Psychiatry 2007, 62:17-24.
24. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. Journal of Affective Disorders 2010, 126:303-311.
25. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Roberts R.C., et al. Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2009, 80:19-26.
26. McNamara R.K., Jandacek R., Rider T., Tso P., Hahn C.G., Richtand N.M., et al. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophrenia Research 2007, 91:37-50.
27. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Research 2008, 160:285-299.
28. McNamara R.K., Liu Y. Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. Journal of Affective Disorders 2011, 129:359-363.
29. Olsson N.U., Shoaf S.E., Salem N. The effect of dietary polyunsaturated fatty acids and alcohol on neurotransmitter levels in rat brain. Nutritional Neuroscience 1998, 1:133-140.
30. Orr S.K., Bazinet R.P. The emerging role of docosahexaenoic acid in neuroinflammation. Current Opinion in Investigational Drugs 2008, 9:735-743.
31. Phelps E.A. Human emotion and memory: interactions of the amygdala and hippocampal complex. Current Opinion in Neurobiology 2004, 14:198-202.
32. Sarris J., Mischoulon D., Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. The Journal of Clinical Psychiatry 2011.
33. Siever L.J. Neurobiology of aggression and violence. The American Journal of Psychiatry 2008, 165:429-442.
34. Sublette M.E., Ellis S.P., Geant A.L., Mann J.J. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. The Journal of Clinical Psychiatry 2011.
35. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
36. Usher J., Leucht S., Falkai P., Scherk H. Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies. Psychiatry Research 2010, 182:1-8.
37. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. The American Journal of Psychiatry 2000, 157:16-25.
38. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. Journal of Neurotrauma 2004, 21:1457-1467.
39. Wu A., Ying Z., Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155:751-759.
40. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., et al. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neuroscience Letters 1998, 240:177-181.
41. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. The American Journal of Clinical Nutrition 2002, 75:662-667.